About Universita di Siena
The University of Siena in Siena, Tuscany, is one of the oldest and first publicly funded universities in Italy. Originally called Studium Senese, the institution was founded in 1240. It had around 20,000 students in 2006, nearly half of Siena's total population of around 54,000.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
European Organisation for Research and Treatment of Cancer - EORTC
3
Pfizer
2
Università degli Studi di Ferrara
2
Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy
1
Medical University of Graz
1
Merck KGaA, Darmstadt, Germany
1
Wyeth is now a wholly owned subsidiary of Pfizer
1
Clinical Trials at Universita di Siena
During the past decade, Universita di Siena conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on
average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer
2001-09-01
Unknown status
700
Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery
2004-05-01
Unknown status
165
Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
2004-06-01
Unknown status
279
Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma
2005-01-01
Terminated
171
Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis
2005-12-27
2008-03-29
Completed
752
Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients
2008-06-01
2013-08-01
Terminated
901
Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients
2008-01-01
2012-11-01
Terminated
1,100
Evaluation of the Onset of Action in Highly Active MS (MAGNIFY)
2018-05-28
2022-02-21
Completed
270
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Universita di Siena" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials, followed by "Pfizer" with 2 trials
sponsored, "Università degli Studi di Ferrara" with 2 trials sponsored, "Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy" with 1 trials sponsored and "Medical University of Graz"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Universita di Siena"
#1 collaborator was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 1 trials as a collaborator and "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Universita di Siena
According to Clinical.Site data, the most researched conditions in "Universita di Siena" are
"Alzheimer Disease" (2 trials), "Acute Kidney Injury" (1 trials), "Bladder Cancer" (1 trials), "Diabetes Mellitus, Type 1" (1 trials) and "Intraocular Melanoma" (1 trials). Many other conditions were trialed in "Universita di Siena" in a lesser frequency.
Clinical Trials Intervention Types at Universita di Siena
Most popular intervention types in "Universita di Siena" are "Drug" (8 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "bapineuzumab" (2 trials), "placebo" (2 trials), "Comprehensive evaluation" (1 trials) and "D1/3-MAGE-3-His fusion protein" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Universita di Siena
The vast majority of trials in "Universita di Siena" are
11 trials for "All" genders.
Clinical Trials Status at Universita di Siena
Currently, there are NaN active trials in "Universita di Siena".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Universita di Siena,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Universita di Siena, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Universita di Siena
Universita di Siena has several departments that took part in Clinical trials: "Siena University, Department of Periodontology, Policlinico Le Scotte Siena." - 4 trials, "Tuscan School of Dentistry" - 4 trials
Departments List
Name
City
Trials